...
首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Using the multiple sclerosis impact scale to estimate health state utility values: Mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D
【24h】

Using the multiple sclerosis impact scale to estimate health state utility values: Mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D

机译:使用规模多发性硬化的影响评估健康状态效用值:映射从MSIS-29 EQ-5D和版本2

获取原文
获取原文并翻译 | 示例

摘要

Objectives: The 29-item Multiple Sclerosis Impact Scale (MSIS-29) is a psychometrically validated patient-reported outcome measure increasingly used in trials of treatments for multiple sclerosis. However, it is non-preference-based and not amenable for use across policy decision-making contexts. Our objective was to statistically map from the MSIS-29, version 2, to the EuroQol five-dimension (EQ-5D) and the six-dimension health state short form (derived from short form 36 health survey) (SF-6D) to estimate algorithms for use in cost-effectiveness analyses. Methods: The relationships between MSIS-29, version 2, and EQ-5D and SF-6D scores were estimated by using data from a cohort of people with multiple sclerosis in South West England (n=672). Six ordinary least squares (OLS), Tobit, and censored least adjusted deviation (CLAD) regression analyses were conducted on estimation samples, including the use of subscale and item scores, squared and interaction terms, and demographics. Algorithms from models with the smallest estimation errors (mean absolute error [MAE], root mean square error [RMSE], normalized RMSE) were then assessed by using separate validation samples. Results: Tobit and CLAD. For the EQ-5D, the OLS models including subscale squared terms, and item scores and demographics performed comparably (MAE 0.147, RMSE 0.202 and MAE 0.147, RMSE 0.203, respectively), and estimated scores well up to 3 years post-baseline. Estimation errors for the SF-6D were smaller (OLS model including squared terms: MAE 0.058, RMSE 0.073; OLS model using item scores and demographics: MAE 0.059, RMSE 0.08), and the errors for poorer health states found with the EQ-5D were less pronounced. Conclusions: We have provided algorithms for the estimation of health state utility values, both the EQ-5D and SF-6D, from scores on the MSIS-29, version 2. Further research is now needed to determine how these algorithms perform in practical decision-making contexts, when compared with observed EQ-5D and SF-6D values.
机译:目的:29-item多发性硬化的影响规模(MSIS-29)是一种心理测量的验证patient-reported结果测量越来越用于治疗多种试验硬化。不适合使用在政策决策环境。从MSIS-29统计地图,版本2,的EuroQol显示(EQ-5D)和six-dimension健康状态短形式(派生从短形式36健康调查(SF-6D)估计算法用于成本效益分析。MSIS-29,版本2,EQ-5D SF-6D分数被估计使用数据从一个群在南西患有多发性硬化症英格兰(n = 672)。(OLS),托比特书和审查,至少调整偏差(复合)回归分析样本进行估计,包括使用内部氧化物和条目分数,平方交互方面,和人口统计数据。从模型与最小的估计错误(平均绝对误差(MAE),均方根错误(RMSE),归一化均方根误差)被评估通过使用单独的验证样本。托比特书和包。包括内部氧化物平方项,条目分数和人口相对(美0.147,RMSE 0.202和0.147美,RMSE 0.203,分别),估计分数3年post-baseline。SF-6D较小(OLS模型包括的平方0.058术语:梅,RMSE 0.073;0.059条目分数和人口统计:梅,RMSE0.08),对贫穷的健康状态和错误发现EQ-5D不明显。结论:为我们提供了算法评估健康状态的效用值,两者兼而有之EQ-5D SF-6D,从MSIS-29的分数,版本2。确定这些算法执行实用的决策环境,相比和观察EQ-5D SF-6D值。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号